# Optimal Allogeneic PRP Concentration for Oocyte In Vitro Maturation in Women With PCOS

> **NCT07514234** · NA · COMPLETED · sponsor: **Gadjah Mada University** · enrollment: 15 (actual)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome)

## Interventions

- **OTHER:** PRP plasma rich platelets

## Key facts

- **NCT ID:** NCT07514234
- **Lead sponsor:** Gadjah Mada University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-05
- **Primary completion:** 2023-09-11
- **Final completion:** 2025-12-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514234, "Optimal Allogeneic PRP Concentration for Oocyte In Vitro Maturation in Women With PCOS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07514234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*